BioCorRx Inc.

CEOCFO-Members Login

March 31, 2014 Issue

The Most Powerful Name In Corporate News and Information

INDEX  |  CONTACT  |   SERVICES  | HOME

Leading Edge Addiction Treatment Programs

About BioCorRx Inc.

BioCorRx, Inc. is a healthcare solutions development company on the leading edge of addiction treatment programs. The company currently owns an addiction treatment program called the Start Fresh Program (SFP) that is used by various independently owned licensed addiction clinics throughout the United States. The company is currently working on other treatment programs and products that will focus on other health issues and addictions.

The Start Fresh Program (SFP) consists of two components:

1) BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant compound of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol and opioids for as long as a year in some patients, depending on individual metabolism rates. Furthermore, once the implant has dissolved, a vast majority of patients are pleased to discover that their physical cravings continue to remain greatly reduced or even eliminated.

2) BioCorRx also owns a life coaching program that is tailored specifically to alcoholics and other addictions. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary treatment program (SFP) has an 85% success rate as reported by patients that complete the program in routine telephone and face to face interviews conducted by the independently owned and operated clinics using the SFP. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.

Lourdes Felix
CFO

Ms. Felix has been the Chief Financial Officer/Treasurer of the Company since October 1, 2012 and a member of the Board since March 7, 2013. Ms. Felix has been instrumental in assisting in capital procurement and implementing an audit committee. Ms. Felix is a corporate finance executive offering over twenty years of combined experience in public accounting and in the private sector in building, leading, and advising corporations through complex restructurings. She is thoroughly experienced in guiding troubled companies to greater efficiency and profitability. Ms. Felix has acquired expertise in securities laws and knowledge of SOX requirements. She has worked with private and public SEC reporting companies. Ms. Felix was previously the controller for a mid-size public accounting firm for over seven years and was responsible for the operations and financial management of regional offices. Her experience includes a wide variety of industries including advertising, marketing, non-profit organizations, medical practices, mortgage banking, manufacturing and SEC reporting companies. She has assisted companies with documented contributions leading to improved financial performance, heightened productivity, and enhanced internal controls. Ms. Felix is very active in the Hispanic community and speaks fluent Spanish. Ms. Felix holds a Bachelor of Science degree in Business Management and Accounting from University of Phoenix.

“Patients report that quote, unquote, ‘This was a miracle.’” - Lourdes Felix

BioCorRx Inc.

Suite 103, 601 N. Parkcenter Drive

Santa Ana, CA 92705
United States
714-4624880
www.biocorrx.com

 

Interview conducted by: Lynn Fosse, Senior Editor, CEOCFO Magazine, Published – March 31, 2014

CEOCFO: Ms. Felix, what attracted you to the BioCorRx?

Ms. Felix: What initially attracted me to the company was the help that they were giving to the people addicted to alcohol through the Start Fresh Program. During my entire career in the accounting and financial industry, I had always envisioned myself wrapping up the last 10 to 15 years of my career in an industry that gave back to individual people in need. I feel that BioCorRx Inc. is that right place. I have been with BioCorRx Inc. now for about a year and a half and I am very excited with the medical technology that the company continues to develop and provide to people suffering from alcohol and now other addictions across the United States.

CEOCFO: What is the BioCorRx approach to the problem?

Ms. Felix: The approach to the problem is what makes our Company unique; we have a rehabilitation program which includes the use of a proprietary formula in the form of a Naltrexone implant. It is implanted in the patient right underneath the skin and it releases therapeutic levels of the medication over an extended period of time that helps to block the pleasure effects of the alcohol and opioids. Most patients report that they do not have any cravings, almost immediately after the procedure.

CEOCFO: What is it releasing?

Ms. Felix: The implant is a proprietary formulation consisting of the FDA approved drug Naltrexone that was cleared by the FDA for the treatment of alcoholism in 1995. The implant has been able to help patients tremendously in reducing their cravings for alcohol and opioids as well.

CEOCFO: Has a similar approach been tried in the past?

Ms. Felix: Yes, there are other Naltrexone implants out there. Our research shows that they typically last up to 3 months. Our implant has been reported to last anywhere from 6 to 12 months, depending on the person’s metabolism and other factors. This is the superior advantage that the Start Fresh Program has over any other Addiction Programs out there.

CEOCFO: Are there any potential side effects?

Mr. Felix: Patients report soreness around the area after the medical procedure. Typically, the person can go back to work the next day. There is some discomfort but nothing very significant. Some patients may report inflammation around the surgery site and in rare cases, infection can occur as with any other medical procedure. Other side effects from Naltrexone itself can be found on our website FAQ section.

CEOCFO: Who would be a typical candidate for the procedure or is it virtually good across the board?

Ms. Felix: I do not know the correct answer for who would be the correct candidate. What we do know is that there is a multitude of family members who’s loved ones are afflicted with alcoholism and other addictions and are seeking help for them as well as the individuals themselves. The physicians treating the people with this disease are familiar with the parameters and who would be a perfect candidate for the Start Fresh Program.

CEOCFO: Would you tell us about the coaching part of the program?

Ms. Felix: What we have is the Start Fresh program, which consists of the Naltrexone implant but the program also includes a coaching portion of the program. The coaching portion is vitally important. The implant procedure and the coaching go hand and hand. The coaching part of the program will help address the psycho-social issues that possibly led the person to drink to begin with. It gives them time and clarity to address the mental aspect of the demons they are probably dealing with. The clinics report back that their patients have an 85% success rate if they complete the program. This two-prong approach is what makes our program so successful.

CEOCFO: How do you reach clinics that may want to use the Start Fresh programs and what has been the general reception from that community?

Ms. Felix: The predominant business model that we employ is the licensing of our Start Fresh Program in U.S. territories that desire to implement, use and distribute our program. We currently have five licensed clinics that use the Start Fresh program in the U.S. We will speak to anyone in the medical community that has an interest in our program.

CEOCFO: What you are talking with someone, do they understand the concept easily or are there some objections you need to overcome?

Ms. Felix: The fortunate part for us is that the very first licensed clinic in Santa Ana has been treating patients for 4 years now so the success rate speaks for itself. The medical director is familiar with the program.

CEOCFO: Why the change of name from Fresh Start to BioCorRx?

Ms. Felix: We decided to change the name to reflect our new vision which consists of adding more programs and product lines in the near future.

CEOCFO: Are you funded for the steps you would like to take next and will you be seeking additional funding?

Ms. Felix: Funding is something that we are always addressing and considering for our projected future growth. At the moment our current business model has enabled us to secure enough resources to maintain a steady business. We are now poised for a continued expansion and will seek funding as needed.

CEOCFO: How do you get the public to learn about what you are doing?
Ms. Felix: The licensed clinics do marketing and advertising at the clinic level. BioCorRx has launched a National TV campaign in an effort to create awareness about the Start Fresh Program.

CEOCFO: Put it together for our readers. Why consider BioCorRx?

Ms. Felix: BioCorRx has a unique program that directly addresses alcoholism and opioid addiction with a reported 85% success rate. Patients report that quote, unquote, “This was a miracle.” This is something that saved their life, their family, saved their relationship with their spouse. We hear these kind of stories nonstop from our licensed clinics and that their patients say that they are astounded with the program. These patient testimonials are what motivate us to continue to search for other products and programs to add to our product line and help those afflicted with addiction.

disclaimers

Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews.com is prohibited.

Healthcare Solutions Development Company, BioCorRx Inc., CEO Interviews 2014, Leading Edge Addiction Treatment Programs, addiction treatment program called the Start Fresh Program (SFP) used by various independently owned licensed addiction clinics throughout the United States, treatment programs and products focused on other health issues and addictions, Recent CEO Interviews, Healthcare Solutions Stock, Healthcare Stocks, BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant compound of the FDA-approved drug, naltrexone, after being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol and opioids for as long as a year in some patients, depending on individual metabolism rates, once the implant has dissolved, a vast majority of patients are pleased to discover that their physical cravings continue to remain greatly reduced or even eliminated, life coaching program that is tailored specifically to alcoholics and other addictions, the implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work, BioCorRx Inc Press Releases, News, Companies looking for venture capital, Angel Investors, private companies looking for investors, healthcare solutions companies seeking investors, addiction treatment programs companies needing investment capital